ATRIUM HEALTH ANSON
1. Target Overview & Investment Thesis
ATRIUM HEALTH ANSON is a 15-bed suburban community hospital in ANSON, NC with $23.8M in net patient revenue and a 4.5% operating margin. The hospital serves a payer mix of 33.4% Medicare, 5.7% Medicaid, and 60.9% commercial.
Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.5% to 11.9% (+736bps).
| Net Revenue HCRIS | $23.8M |
| Current EBITDA COMPUTED | $1.1M |
| Operating Margin COMPUTED | 4.5% |
| Occupancy HCRIS | 35.8% |
| Revenue / Bed COMPUTED | $1.6M |
| Net-to-Gross HCRIS | 21.0% |
| Distress Probability ML | 50.2% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 4.5% places it above the state median. Among 25 size-comparable peers (8-30 beds), the median margin is -8.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-30), prioritizing same-state peers. 25 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ATRIUM HEALTH ANSON (Target) | NC | 15 | $23.8M | 4.5% |
| THE OUTER BANKS HOSPITAL | NC | 21 | $93.7M | 26.2% |
| MEDICAL PARK HOSPITAL | NC | 22 | $82.6M | 15.8% |
| NORTH CAROLINA SPECIALTY HOSPI | NC | 18 | $71.6M | 11.7% |
| THE MCDOWELL HOSPITAL | NC | 30 | $65.7M | -6.7% |
| CHOWAN HOSPITAL INC. | NC | 25 | $61.5M | 10.4% |
| MURPHY MEDICAL CENTER | NC | 25 | $58.0M | -8.8% |
| J ARTHUR DOSHER MEMORIAL HOSPI | NC | 25 | $57.6M | 3.8% |
| ST LUKES HOSPITAL | NC | 25 | $50.4M | -1.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $501K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $477K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $472K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $290K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $15K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $1.1M |
| + RCM Uplift | +$1.8M |
| Pro Forma EBITDA | $2.8M |
| Current Margin | 4.5% |
| Pro Forma Margin | 11.9% |
| WC Released (1x) | $914K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.6M | $24.6M | 14.93x | 71.7% |
| Base (11x exit) | 10.0x | 11.0x | $1.6M | $27.6M | 16.75x | 75.7% |
| Bull Case | 9.0x | 11.0x | $1.5M | $33.9M | 22.88x | 87.0% |
| Bull (12x exit) | 9.0x | 12.0x | $1.5M | $37.5M | 25.25x | 90.8% |
| Bear Case | 11.0x | 10.0x | $1.8M | $15.3M | 8.44x | 53.2% |
| Bear (11x exit) | 11.0x | 11.0x | $1.8M | $17.4M | 9.61x | 57.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Elevated distress probability | Model estimates 50.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 25 hospitals with 8-30 beds
- Same-state prioritization (n=26)
- Comp margins: P25=-20.3% / P50=-8.8% / P75=2.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.